Nodular mixed cell lymphoma: Is there a potential for a prolonged disease free survival and cure?

摘要: The malignant lymphomas represent a significant contribution to the morbidity and mortality of diseases in United States. It was estimated 1982 that 23 000 new cases lymphoma will be diagnosed, 12 600 deaths occur. By disease site, is one ten most common malignancies, eight fatal malignancies. Although this rate high (over 50%), appears decreasing with introduction more effective modalities treatment for at their various stages disease. This therapy represents incorporation better histopathological classification systems, supportive medical care improved programs. In addition, development systematic staging procedures identify otherwise occult has been an important addition our management these patients. These techniques have not only allowed appropriate application initial therapy, but identified sites need re-evaluated time completion therapy.